European Academy of Allergy and Clinical Immunology
EAACI Leadership Reflects on Record-Breaking Congress 2025: A Pivotal Moment for Allergy and Immunology
EAACI Leadership Reflects on Record-Breaking Congress 2025: A Pivotal Moment for Allergy and Immunology
ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- With over 7,600 delegates in attendance, EAACI Congress 2025 made headlines not just for its scale but for the powerful message delivered by its leadership. Now, one month after the Congress concluded in Glasgow, EAACI’s top figures are sharing their reflections on what they call a turning point for the field. Held from 13–16 June at the Scottish Event Campus, the event championed the theme: “Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future.”
“This year’s Congress was a turning point,” said Prof. Maria Torres, EAACI President. “We are entering an era where scientific innovation, equity in care, and environmental health must move forward together.”
The programme featured over 250 hours of lectures, workshops, and symposia, covering groundbreaking advances in drug allergy, T2 inflammation, paediatric asthma, and hereditary angioedema. The Presidential Symposium tackled antimicrobial resistance through a One Health lens, while a timely session on climate change and insect allergy drew global attention to ecological impacts on patient care.
Far beyond the walls of the SEC, the EAACI Congress 2025 activated the entire city with initiatives that brought science to the streets. The Clinical Village at the Glasgow Science Centre welcomed the public for hands-on allergy education, while the Beat Allergy Walk & Run raised funds for the Glasgow Children’s Hospital Charity, reinforcing EAACI’s commitment to social impact and community engagement.
“The spirit of collaboration we witnessed in Glasgow was extraordinary,” said Prof. André Moreira, EAACI Vice President Congresses. “This energy is now translating into real-world initiatives and global partnerships.”
The Congress also highlighted EAACI’s dedication to mentorship, digital health innovation, and amplifying patient’s voices.
The countdown for the EAACI Congress 2026 in Istanbul has officially begun, but you won’t have to wait until then to dive back into cutting-edge science. From focused meetings to hands-on courses, EAACI has a packed calendar to keep you inspired all year long. Check out what’s coming next at https://eaaci.org.
About EAACI
The European Academy of Allergy and Clinical Immunology (EAACI) is Europe’s largest professional association in the field, committed to advancing research and care for those affected by allergic diseases.
Learn more: https://eaaci.org
Contact: communications@eaaci.org | +41 44 205 55 33
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/60c21700-f7c9-486c-a72f-f699174a926a

Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zealand Pharma18.7.2025 18:30:00 CEST | Press release
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
SpringWorks Therapeutics, Inc.18.7.2025 17:30:40 CEST | Press release
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Photocat A/S18.7.2025 17:00:00 CEST | Press release
PHOTOCAT has today applied for a transfer of its trading venue from Nasdaq First North Growth Market to Spotlight Stock Market.
Golden Ocean Group Limited18.7.2025 16:30:00 CEST | Press release
GOGL – Notice of Special General Meeting
Kapitalforeningen SDG Invest18.7.2025 16:06:31 CEST | Pressemeddelelse
Kapitalforeningen SDG Invest - Opdateret prospekt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom